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Abstract
Background— Prior research indicates that conduct disorder (CD) is associated with a range of
comorbid mental disorders. However, the actual prevalence, subtypes, and patterns of comorbidity
of DSM-IV defined CD in the general U.S. population remains unknown.
Method— Retrospective assessment of CD and other DSM-IV disorders was conducted using fully
structured diagnostic interviews among a nationally representative sample of respondents (n = 3,199)
in the National Comorbidity Survey Replication.
Results— The estimated lifetime prevalence of CD in the U.S. is 9.5% (males = 12.0%, females =
7.1%), with a median age-of-onset of 11.6 (0.2) years. Latent class analysis identified five CD
subtypes characterized by rule violations, deceit/theft, aggression, severe covert behaviors, and
pervasive CD symptoms. A dose-response relationship was revealed between CD subtype severity
and risk of subsequent disorders. Results also indicated that CD typically precedes mood and
substance use disorders, but most often occurs after impulse control and anxiety disorders. Although
both active and remitted CD is associated with increased risk of the subsequent first onset of other
mental disorders, remitted CD is associated with significantly lower risk of subsequent disorders.
Conclusions— CD is prevalent and heterogeneous in the U.S. population, and more severe
subtypes and the presence of active CD are associated with higher risk of comorbid disorders. Future
prospective studies using general population samples will further inform the nature and course of
this disorder.
Conduct disorder (CD), as defined in the DSM-IV, is characterized by a pervasive and
persistent pattern of aggressive, deceptive, and destructive behavior that usually begins in
childhood or adolescence. CD symptoms are the primary presenting problems for psychiatric
referral among children and adolescents in the U.S. (Kazdin, 1995;Robins, 1991), and youth
diagnosed with CD report higher levels of distress and impairment in virtually all domains of
living than youth with other mental disorders (Lambert, Wahler, Andrade, & Bickman,
2001). Moreover, prior prospective studies have shown that conduct problems during
childhood or adolescence are associated with significantly increased risk of other mental
disorders, legal problems, and premature mortality (Kim-Cohen et al., 2003;Laub & Vaillant,
2000;Pajer, 1998;Robins, 1966;Simonoff et al., 2004).
Despite the significance of CD, many basic questions about the disorder remain unanswered.
First and foremost, the general population prevalence of CD in the U.S. is currently unknown.
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Several prior studies have used DSM-IV criteria to evaluate the prevalence of CD in other
countries (Moffitt, Caspi, Rutter, & Silva, 2001) or in selective samples within the U.S.
(Costello, Mustillo, Erkanli, Keeler, & Angold, 2003), but these data are of limited use in
estimating the prevalence of CD in the general U.S. population. Based on these prior studies,
the lifetime prevalence of CD has been estimated at between 6% and 16% for males and 2%
and 9% for females in the U.S. (Loeber, Burke, Lahey, Winters, & Zera, 2000;Maughan, Rowe,
Messer, Goodman, & Meltzer, 2004). However, in addition to limitations in the sampling
procedures used these estimates are based on DSM-III and DSM-III-R criteria. Given that even
minor changes in the diagnostic criteria of CD have been shown to result in major differences
in prevalence (Boyle et al., 1996;Loeber, Burke et al., 2000), these estimates are unlikely to
represent the prevalence of DSM-IV CD accurately.
Questions also exist about the presence of CD subtypes. A DSM-IV diagnosis of CD requires
the presence of any three of 15 symptoms. This means that 32,647 distinct symptom profiles
qualify for a diagnosis of CD. DSM-IV proposes subtypes based on developmental patterns of
onset (i.e., “childhood onset” versus “adolescent onset” CD). There is evidence supporting this
general developmental distinction (Moffitt & Caspi, 2005); however, the identification of more
precise subtypes based on symptom content could be useful in bringing order to the enormous
variety of symptom profiles possible, and may reveal important distinctions in etiology, course,
and treatment response. Toward this end, DSM-IV also classifies symptoms according to four
main clusters (i.e., “aggression to people and animals,” “destruction of property,”
“deceitfulness or theft,” and “serious violations of rules”). To date, empirical justification for
these classes is lacking, as is information about the relation of such classes to course of illness,
comorbidity, or treatment response. Prior studies have suggested alternative classification
schemes for CD symptoms, making distinctions between overt (e.g., physical assault) and
covert (e.g., shoplifting) symptoms, destructive and non-destructive symptoms, proactive and
reactive aggression, socialized and unsocialized subtypes, and based on the presence versus
absence of callous-unemotional traits and specific comorbities (Dodge, Lochman, Harnish,
Bates, & Pettit, 1997;Frick & Ellis, 1999;Frick et al., 1993;Rutter, Giller, & Hagell, 1998).
The fact that empirical support exists for each of these dichotomous distinctions suggests that
a more textured and multidimensional classification system is needed to characterize subtypes
comprehensively.
There also are questions regarding the widely documented comorbidity of CD with other
mental disorders (Kim-Cohen et al., 2003;Lahey, Loeber, Burke, Rathouz, & McBurnett,
2002;Lahey, Miller, Gordon, & Riley, 1999;Loeber, Burke et al., 2000;Maughan et al.,
2004). Although it is clear that CD is associated with other disorders, little is known about
whether comorbid disorders precede or follow the onset of CD, whether comorbidities differ
by CD subtype, or whether CD is associated with the adult persistence of comorbid disorders.
Studies addressing these questions have relied on data from relatively small, selective samples,
such as those seeking treatment or those from a specific geographic location. Results from such
studies may reflect idiosyncratic characteristics that are of limited generality to the larger
population.
The current study examines the prevalence, age-of-onset, and empirically-defined subtypes of
DSM-IV CD in the National Comorbidity Survey Replication (NCS-R) (Kessler et al.).
Individual-level comparisons of retrospectively reported age-of-onset of comorbid disorders
are used to examine the presence and timing of these disorders in relation to CD. Although the
use of retrospective reporting may introduce limitations such as under-reporting and recall bias,
such methods can provide valuable data where no prospective studies exist (Schlesselman,
1982). The current study provides preliminary information on CD that is immediately
beneficial to researchers, clinicians, and health care policy experts, and can inform future
prospective studies in this area. Data from the NCS-R have recently shed light on the
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prevalence, course, and correlates of other disorders (e.g., Kessler, Adler et al., 2005;Kessler,
Berglund, Borges, Nock, & Wang, 2005;Kessler, Brandenburg et al., 2005); however, no prior
studies have provided data on CD.
METHOD
Sample
Data are from the National Comorbidity Survey Replication (NCS-R), a face-to-face household
survey of 9,282 English-speaking adults ages 18+ in the coterminous United States that was
based on a nationally representative multi-stage clustered area probability sampling design
(Kessler et al., 2004). The response rate was 70.9%. Respondents received information about
the study via an advance letter and a Study Fact Brochure followed by a household
informational visit before providing informed consent and carrying out the interview. Consent
was obtained verbally rather than in writing in order to match the baseline NCS procedures for
purposes of comparing the two surveys. These recruitment and consent procedures were
approved by the Human Subjects Committees of Harvard Medical School and the University
of Michigan.
The NCS-R was administered in two parts. Part I included demographic and diagnostic
assessments administered to all 9,282 respondents. Part II included additional questions
administered to all respondents who met criteria for at least one mental disorder during the Part
I interview and a probability sub-sample of other respondents. Given concerns about recall
failure among older adults in the assessment of disorders of childhood and adolescence, CD
was assessed among only the 3,199 Part II respondents in the age range 18–44. This sample
was weighted to adjust for the over-sampling of Part I respondents with other DSM-IV
disorders as well as to correct for differential probability of selection and non-response. More
details on NCS-R sampling and weighting are presented elsewhere (Kessler et al., 2004).
Assessment
Mental disorders were assessed in the NCS-R with the World Health Organization (WHO)
Composite International Diagnostic Interview (CIDI) (Kessler & Ustun, 2004). The CIDI is a
fully structured lay-administered diagnostic interview that generates diagnoses according to
the definitions and criteria of both the DSM-IV and the ICD-10 diagnostic systems. DSM-IV
criteria are used in the current report. Four classes of core disorders were assessed: mood
disorders, anxiety disorders, substance use disorders, and impulse-control disorders. DSM-IV
organic exclusion rules and diagnostic hierarchy rules were used in making all these diagnoses.
Good concordance has been found in an NCS-R clinical reappraisal sub-sample between
diagnoses of anxiety, mood, and substance use disorders based on the CIDI and diagnoses
based on blinded clinical reappraisal interviews using the Structured Clinical Interview for
DSM-IV (SCID) (First MB, 2002) (see Kessler, Berglund, Demler et al., 2005). Diagnoses of
impulse-control disorders, including CD, were not validated because these diagnoses are not
included in the SCID.
Data Analytic Plan
Latent class analysis (LCA), a data reduction method that allows for non-additive associations
among variables (Heinen, 1996;McCutcheon, 1987), was used to identify CD subtypes from
the 15 CD symptoms. Current socio-demographic correlates of CD and the latent classes were
estimated using logistic regression analyses. The associations of CD with other mental
disorders were also examined with logistic regression equations, controlling for age (in 10-
year intervals), sex, and race/ethnicity. Temporal priorities in first onset of CD (i.e., age at first
having symptoms of CD) compared to comorbid disorders were examined using information
obtained in retrospective age-of-onset reports. The effect of CD in predicting the first onset of
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subsequent disorders was examined using the same retrospective age-of-onset reported to
estimate discrete-time survival models with information about the presence and absence of CD
coded as time-varying predictor variables (Willett & Singer, 1993). Information about offset
of CD (i.e., age at last having symptoms of CD) was used in these survival analyses to
investigate whether recovery from CD is associated with a reversal of the elevated risk of
secondary disorders. The comparative effects of active and remitted CD latent classes in
predicting the subsequent onset and persistence of secondary disorders were examined, finally,
in a more elaborate series of survival models. Coefficients from logistic regression and survival
analyses were transformed to odds-ratios (ORs) by exponentiation for ease of interpretation.
Similar transformations were made of the coefficients plus-minus 1.96 standard errors to
generate 95% confidence intervals (95% CIs) of the ORs. All parameters were estimated using
the Taylor series linearization method (Wolter, 1985), a design-based method implemented in
the SUDAAN software system (SUDAAN, 2002), to adjust for the weighting and clustering
of the NCS-R data. Statistical significance was evaluated using two-sided design-based .05
level tests.
RESULTS
Prevalence of CD
The lifetime prevalence of DSM-IV CD is estimated to be 9.5% (12.0% among males and 7.1%
among females). The prevalence of individual CD symptoms varies substantially, from a high
of 32.8% who report repeatedly staying out at night without parental permission to a low of
0.3% who report forced sexual activity (Table 1).
CD Subtypes
Latent class analysis (LCA) was used to identify discrete subtypes of CD. The best-fitting LCA
solution produced six latent classes (Table 1). Class 1 is characterized by a low probability of
each symptom and by the presence of an average of less than one CD symptom per respondent.
We refer to this class as “No CD.” Class 2 is characterized by a symptom profile consistent
with the “rule violations” grouping in DSM-IV, including items related to: staying out late,
skipping school, and running away overnight. Respondents in the Rule Violations class report
an average of 3.1 CD symptoms and compose 25.7% of those who met lifetime criteria for CD.
Class 3 is characterized by a symptom profile consistent with the “deceit/theft” grouping in
DSM-IV. Respondents in the Deceit/Theft class report an average of 3.0 CD symptoms and
compose 13.4% of those with lifetime CD. Class 4 is characterized by endorsement of
symptoms consistent with the “aggression to people and animals” grouping in DSM-IV.
Respondents in this Aggressive class, like those in the Deceit/Theft class, report an average of
approximately three CD symptoms, but the Aggressive class is less prevalent, comprising only
3.2% of those with a lifetime diagnosis of CD. Also, individuals in the Aggressive class who
meet criteria for CD have an earlier median age-of-onset of CD (7.0 years) than individuals in
the other classes (12.0 to 14.0 years). Class 5 is characterized by endorsement of the symptoms
common in both the Rule Violations and Deceit/Theft classes, as well as with more severe
symptoms not endorsed in the earlier classes, such as breaking into cars and buildings and
damaging property. Respondents in this class report an average of 6.4 CD symptoms and make
up 28.6% of those with a lifetime diagnosis of CD. We term this class “severe covert.” Finally,
Class 6 is characterized by increased probability of each CD symptom. Respondents in this
class report an average of 8.2 CD symptoms and compose 29.1% of those with CD. We term
this class “pervasive CD.” In summary, six latent classes were identified characterizing five
CD subtypes. The first three subtypes showed quite distinct symptom patterns and the last two
subtypes showed some overlap of symptoms and increased symptom number and severity.
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Sociodemographic Correlates of CD and CD Subtypes
Lifetime diagnosis of CD is associated with young age, male gender, low educational
attainment, being separated or divorced, residing in the Western U.S., and residing in urban
settings. Those identifying as Hispanic have a significantly lower rate of CD than those
identifying as Non-Hispanic White (Table 2).
Sociodemographic correlates of each CD subtype were identified by comparing membership
in Class 2 (Rule Violations) with each subsequent class. Overall, the subtypes are composed
of an increasing percentage of males. Membership in the Theft/Deceit subtype is associated
with a higher educational level, but lower likelihood of being currently employed. Membership
in the Aggressive subtype is associated with younger age cohort, Black ethnicity, lower
likelihood of being married, lower income, greater likelihood of being from the Midwest, and
lower likelihood of residing in the suburbs. Membership in both the Severe Covert and
Pervasive CD subtypes is associated with being previously married (i.e., divorced, separated,
or widowed), and the Pervasive CD subtype is associated with a lower likelihood of living in
the suburbs (i.e., greater likelihood of living in the city).
Mental Disorders Associated with CD
Lifetime diagnosis of CD is associated with significantly elevated risk of all other mental
disorders assessed, with the exception of agoraphobia (Table 3). The presence of CD is
associated with an especially elevated risk for substance use disorders (OR = 5.9) and impulse-
control disorders (OR = 7.7). The temporal relationship between CD and other lifetime
disorders differs substantially across disorders. CD is much more likely to occur before
comorbid mood disorders (CD is first 70.2% of the time) and substance use disorders (CD is
first 88.5% of the time). In comparison, CD is more likely to occur after comorbid impulse-
control disorders (CD is first 23.2% of the time). The temporal order between CD and comorbid
anxiety disorders is mixed, with CD primarily occurring after specific and social phobia, but
before all the other anxiety disorders assessed (CD is first 32.1% of the time).
In addition to knowing that CD is associated with increased risk of subsequent secondary
disorders, it would be useful to know if this increased risk is present only during the time CD
is active or if it continues even after CD has remitted. This question was examined using
discrete-time survival analyses to predict the first onset of other disorders from temporally
primary CD, distinguishing between active and remitted CD based on reported age-of-offset
(Table 4). Results show that both active (OR’s = 2.8 – 7.2) and remitted CD (OR’s = 1.6 –
2.9), relative to non-cases, are associated with significantly increased risk of all later disorders.
However, the risk of other mental disorders is significantly higher for active compared to
remitted CD (OR’s = 1.6 – 2.5).
CD Subtypes as Predictors of Other Mental Disorders
In order to determine whether the CD subtypes identified in the LCA provide information about
subsequent risk of other mental disorders, we tested the extent to which CD class membership
(i.e., subtype) predicts first onset of later mental disorders in discrete-time survival models
statistically controlling for age, sex, and race-ethnicity (Table 5). Results show that risk of
comorbid mental disorders varies among respondents with active CD as a function of CD class,
with higher classes consistently associated with greater risk of subsequent mental disorders.
This dose-response relation is evident across all diagnostic groups. A weaker and less consistent
association between CD class and risk of subsequent onset of mental disorders is present for
remitted CD.
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CD as a Predictor of the Persistence of Mental Disorders
The extent to which CD is associated with the persistence of comorbid disorders, defined as
12-month prevalence among lifetime cases, was examined by estimating logistic regression
equations to predict 12-month disorders among lifetime cases, controlling for age-of-onset and
time since onset. Broad classes of comorbid disorders (i.e., any anxiety, mood, impulse-control,
and substance use disorder) were examined here due to restricted statistical power in studying
persistence of individual disorders. CD predicted higher persistence of comorbid anxiety
disorders (OR = 1.5, p = .038) but not other broad classes of comorbid disorders (OR’s = 1.1
– 1.5, p = .765 – .155). The significant effect of CD in predicting persistence of anxiety disorders
did not differ significantly by CD class (χ224 = 2.5, p = .644).
DISCUSSION
This study provides new information about the prevalence, subtypes, and correlates of DSM-
IV CD in the U.S. The estimated lifetime prevalence of 9.5% is in the middle of the range of
previous estimates based on DSM-III and DSM-III-R criteria (Lahey et al., 1999;Loeber, Burke
et al., 2000;Maughan et al., 2004). The prevalence of individual CD symptoms varies widely
and the median age-of-onset for CD is 11.6 (0.2). Consistent with prior reports, CD is
significantly more prevalent among boys (12.0%) than girls (7.1%), and is associated with low
education, marital disruption, and urban residence (Lahey et al., 2002;Lambert et al.,
2001;Loeber & Keenen, 1994). In addition, CD is estimated to be significantly more prevalent
in the West than in other regions of the country. We are unaware of any prior studies
demonstrating a higher prevalence of CD in the Western U.S. Notably though, the baseline
NCS revealed a significantly increased risk of anti-social personality disorder in the Western
U.S. relative to other parts of the country (OR = 2.40) (Kessler et al., 1994). The reason for
this higher rate of such behavior in the Western U.S. is unclear and should be examined further
in subsequent studies.
The current study used latent class analysis (LCA) to identify empirically-derived CD subtypes.
Prior attempts to elucidate subtypes of CD have relied largely on factor analyses of items from
child behavior rating scales (Dodge et al., 1997;Frick & Ellis, 1999;Frick et al., 1993). We
chose to use LCA rather than factor analysis because the latter, unlike factor analysis, allows
for the examination of complex non-additive multivariate profiles among symptoms (Heinen,
1996;McCutcheon, 1987). The LCA of DSM-IV symptoms generated a much more complex
characterization of CD subtypes than prior studies and revealed five subtypes of CD: three
specialized (Rule Violations, Deceit/Theft, and Aggressive) and two more general and more
severe (Severe Covert and Pervasive CD). This five-category system bears important
similarities to dichotomous schemes proposed in prior studies, but synthesizes the earlier
schemes in a way that documents greater complexity and variation in severity than in any of
the dichotomous classifications. Two similarities of this sort are especially noteworthy. First,
the Aggressive and Severe Covert classes are composed of “destructive” symptoms, while the
Rule Violations and Deceit/Theft classes are composed of “non-destructive” symptoms,
replicating the distinction between destructive and non-destructive symptoms found in some
prior studies (Frick & Ellis, 1999;Frick et al., 1993). Second, the Rule Violations, Deceit/Theft,
and Severe Covert classes consist of “covert” symptoms, while the Aggressive and Pervasive
CD classes contain “overt” symptoms, replicating the overt-covert distinction found in other
prior studies (Achenbach, Conners, Quay, Verhulst, & Howell, 1989;Frick & Ellis, 1999;Frick
et al., 1993). In addition to capturing these previously documented distinctions, the five-
category scheme includes a severity distinction in which two subtypes (Severe Covert and
Pervasive CD) are composed of combinations of narrower subtypes.
Several additional features of the current subtyping system warrant brief comment. Although
CD is often thought of as being characterized by aggressive behavior, it is interesting that pure
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aggression is only one subtype of CD. Although the Aggressive subtype has the earliest age-
of-onset it is the least prevalent subtype overall. Instead, the most common symptoms are those
involving Rule Violations (e.g., staying out late, skipping school) and Deceit/Theft (e.g., lying,
stealing), highlighting the prominence of non-aggressive behaviors in the diagnosis of CD.
The finding that CD is associated with increased risk of other mental disorders is consistent
with prior studies (Lahey et al., 2002;Lambert et al., 2001;Loeber & Keenen, 1994), but the
current study advances research on this topic in several ways. First, whereas most studies have
focused on treatment-seeking samples of children (e.g., Lahey et al., 2002;Lambert et al.,
2001), the current study examined comorbid mental disorders in a nationally representative
sample, providing greater generality to the general population. Second, this study assessed
comorbid disorders that occur into adulthood, and perhaps more importantly examined the
timing of CD in relation to these other disorders. The current study revealed that CD is
temporally primary to most other disorders with the notable exception of impulse control
disorders and specific and social phobias. The temporal precedence of these disorders to CD
fits with previous work suggesting an early age-of-onset for impulse-control disorders and
phobias (Dadds & Barrett, 2001;Lahey & Loeber, 1994;Loeber, Green, Lahey, Frick, &
McBurnett, 2000;Schneier, Johnson, Hornig, Liebowitz, & Weissman, 1992).
Although CD appears to precede most comorbid disorders, future studies are needed to further
elucidate the nature of these relations. One possibility is that CD and these other disorders have
common causes. For example, a predisposition to engage in risky or potentially destructive
behaviors may promote both CD and substance use disorders, suggesting homotypic continuity
over time. Another possibility is that CD may play a causal role in the development of
subsequent disorders. For example, CD might cause life stressors that predispose an individual
to secondary major depression, which could explain the heterotypic continuity that was also
observed. We shed some light on these issues by examining the relationships between CD
persistence and the onset of secondary disorders. If CD is a causal risk factor for comorbid
disorders, its effect in predicting the onset and persistence of other disorders should diminish
when CD is remitted. However, if CD is a risk marker for more fundamental causes that remain
active after its remission, it should still be related to the onset and persistence of other disorders
whether it was active or remitted (Kazdin, Kraemer, Kessler, Kupfer, & Offord, 1997;Kraemer
et al., 1997). Our finding that respondents with a history of CD remain at elevated risk of other
disorders even after CD has remitted raises the possibility that CD is a risk marker for
unmeasured common causes of subsequent mental disorders. However, it is also possible that
CD has lasting negative consequences that persist even after the disorder has remitted (e.g., a
criminal record), or that once remitted, CD may have been replaced with symptoms of related
adult disorders such as antisocial personality disorder. We also found that active CD is
associated with much greater risk of later disorders than is remitted CD, raising the possibility
that CD might be not only a risk marker but also a causal risk factor for later disorders. Overall,
the findings that onset of CD is associated with a significant increase in risk and that remission
of CD is associated with a significant decrease in risk of later disorders cannot be used to make
legitimate causal inferences. These results highlight the potential importance of increasing the
proportion of youth with CD who receive effective treatment (e.g., Nock, 2003). Indeed, the
provision of these interventions may not only decrease the symptoms and immediate
consequences of CD, but also may decrease the risk of subsequent disorders.
Importantly, respondents with more severe subtypes of active CD were at increasingly higher
risk for other mental disorders. This dose-response relationship was present across all classes
of mental disorders, but was especially strong in predicting the first onset of comorbid impulse-
control and substance use disorders, even after statistically controlling for age, sex, and
ethnicity. Prior research has demonstrated the importance of age-of-onset of antisocial
behaviors in predicting comorbid mental disorders (Moffitt & Caspi, 2005;Moffitt, Caspi,
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Harrington, & Milne, 2002). The current subtyping system provides additional information
about aspects of CD symptoms that predict subsequent disorders. Indeed, the dose-response
relationship between severe CD subtypes and risk of other disorders cannot be explained solely
by CD age-of-onset, as age-of-onset was not earlier in severe subtypes. Moreover, an advantage
of the current subtyping system is that it considers CD symptom content, rather than timing
and course of symptoms, and therefore can be used to classify individuals at the time of
assessment, rather than requiring time to determine if symptoms are limited to childhood or
adolescence. Future research should examine whether these subtypes are useful in predicting
treatment response. It is possible that the limited effectiveness of some intervention and
prevention programs is due to the application of uniform programs to a heterogeneous group
of individuals. Tailoring treatment to CD subtype may prove useful in increasing treatment
effectiveness.
The most important limitation of the current study is the use of retrospective self-report to
examine CD and other disorders. Respondents may have forgotten events, made errors
regarding the timing of events, or may have been biased by current mood states. The use of
retrospective self-report is likely to have resulted in an under-estimate of the prevalence of CD
and to have introduced inaccuracies in the reported age-of-onset of CD and other disorders.
Specifically, prior work has shown that age-of-onsets reported retrospectively tend to be higher
than those reported prospectively and that retrospective recall may be less accurate in the
reporting of minor offenses (Kazemian & Farrington, 2005). The current findings should be
interpreted with each of these limitations in mind. On balance, several systematic reviews have
concluded that despite such problems, adults recall childhood experiences with sufficient
accuracy to provide useful information in retrospective studies (Brewin, Andrews, & Gotlib,
1993;Hardt & Rutter, 2004;Maughan & Rutter, 1997). The fact that estimates of lifetime
prevalence and age-of-onset of CD obtained in the current study are consistent with figures
obtained in prior prospective studies (Lahey et al., 1999;Maughan et al., 2004) provides support
for the reliability of the current findings.
A related concern is that we did not obtain information to validate respondents’ report of CD
and other mental disorders, such as reports by third-party informants or the use of a clinical
reappraisal interview. Some individuals may have been reluctant to report symptoms such as
forced sexual activity and cruelty to animals given the illegality of these behaviors. In studies
of CD among children and adolescents, these concerns are assuaged by obtaining information
from adults familiar with the child. However, informant reports are much more difficult to
obtain for adults, and such informants are unlikely to be able to provide accurate information
about the respondents’ history of CD and other disorders. Another limitation of the current
study is that we evaluated a relatively narrow range of potential outcomes associated with CD.
For instance, the effect of CD diagnosis and specific CD subtypes on role impairment,
criminality, and physical injury were not examined. These outcomes have been linked to CD
diagnoses in previous reports, and future studies should examine these relations in greater
detail.
The current retrospective study provides important new information about the epidemiology
of CD. Several ongoing prospective studies of CD exist; however, such studies focus on
relatively small and selective samples and take many years to complete, especially those that
follow youth into adulthood. Given the significant personal and societal costs of CD, multiple
methodologies are warranted and needed, including the use of both prospective and
retrospective studies. The continued use of these multiple approaches, and the convergence of
findings across approaches, will ensure ongoing progress in the study of this important behavior
problem.
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